Recurrent Disease

21 registered clinical trials studyying Recurrent Disease — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs NCT06014619	Maastricht University Medical Center	—
Recruiting	Pilot Trial for Treatment of Recurrent Glioblastoma NCT05432518	AHS Cancer Control Alberta	EARLY_Phase 1
Recruiting	Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN NCT05260671	Eye & ENT Hospital of Fudan University	Phase 2
Completed	Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia ( NCT03792256	Children's Oncology Group	Phase 1
Completed	Stepped-Care Telehealth for Distress in Cancer Survivors NCT03060096	Wake Forest University Health Sciences	N/A
Unknown	A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas NCT03591666	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University	Phase 2
Terminated	Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tum NCT03525392	Ipsen	Phase 1
Terminated	Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle NCT02488512	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	Phase 2
Unknown	Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggres NCT02747732	Meirav Kedmi MD	Phase 2
Completed	Proton Beam Re-Irradiation in Thoracic Cancers NCT02204761	University of Washington	N/A
Completed	Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts NCT03415477	Peking University People's Hospital	Phase 1 / Phase 2
Terminated	Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma NCT01794845	University of Miami	Phase 2
Completed	Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent o NCT01737450	Centre Leon Berard	Phase 2
Terminated	Efficacy of SU 011248 in Head And Neck Carcinoma NCT00408252	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	Phase 2
Completed	Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Ph NCT00383474	National Cancer Institute (NCI)	Phase 1
Completed	Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases NCT00351975	National Cancer Institute (NCI)	Phase 1
Completed	Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia NCT01445080	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Tr NCT00036738	Fred Hutchinson Cancer Center	Phase 2
Completed	Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferent NCT02210858	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by NCT00003145	Fred Hutchinson Cancer Center	Phase 2
Unknown	Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence NCT06088719	KK Women's and Children's Hospital	—